Results 31 to 40 of about 9,182 (184)

Is it Pemphigus Vulgaris or toxic epidermal necrolysis? A dilemmatic condition to confirm diagnosis

Padjadjaran Journal of Dentistry, 2008
Pemphigus Vulgaris and Toxic Epidermal Necrolysis both are life threatening diseases. Pemphigus Vulgaris is a mucocutaneous autoimmune disease while Toxic Epidermal Necrolysis is cutaneous drug hypersensitive reaction.
E Fitriana Sari, Titiek Setyowati
doaj   +1 more source

Toxic epidermal necrolysis induced by lamotrigine treatment in a child [PDF]

Korean Journal of Pediatrics, 2014
Toxic epidermal necrolysis is an unpredictable and severe adverse drug reaction. In toxic epidermal necrolysis, epidermal damage appears to result from keratinocyte apoptosis.
Youngsuk Yi, Jeong Ho Lee, Eun Sook Suh
doaj   +1 more source

Clinical features of Stevens — Johnson syndrome and toxic epidermal necrolysis: An observational cohort retrospective study

Кубанский научный медицинский вестник
Background. Stevens — Johnson syndrome and toxic epidermal necrolysis are severe diseases featuring lesions of the mucous membranes and skin, with a possible lethal outcome. These diseases are most often triggered by various infections and medications, e.
G. M. Nurtdinova, E. S. Galimova, O. I. Kucher, D. D. Gazizova, A. F. Galyautdinov, Z. R. Khismatullina, N. Sh. Zagidullin   +6 more
doaj   +1 more source

Fatal case of cephalexin-induced toxic epidermal necrolysis

SAGE Open Medical Case Reports, 2014
Purpose: To describe a case of toxic epidermal necrolysis likely caused by cephalexin with a review of the literature. Case: An 80-year-old male with a known allergy to cephalosporins, residing at a long-term acute care hospital, received cephalexin for ...
Matthew J Hafermann, Gerard R Barber, Stephen C Dreskin, Gordon K Lindberg   +3 more
doaj   +1 more source

Intravenous -acetylcysteine in severe cutaneous drug reaction treatment: A case series

SAGE Open Medical Case Reports, 2020
Drug-induced serious adverse reaction is an unpleasant event with high rate of mortality. Stevens–Johnson Syndrome and toxic epidermal necrolysis are most common among the serious adverse drug reactions.
Md Jahidul Hasan, Raihan Rabbani
doaj   +1 more source

Increased predisposition of sjs ten in COVID-19 patients, presenting as post COVID complication: Report of two cases

Indian Dermatology Online Journal, 2022
We report two consecutive cases of toxic epidermal necrolysis presented to our emergency department in the past 5 months. Both patients had history of fever prior to the onset of skin manifestations and showed radiological findings suggestive of COVID-19
Shayna Aulakh, Raina Arora, Rishu Sarangal, Dimple Chopra   +3 more
doaj   +1 more source

Acute compartment syndrome of the forearm as a rare complication of toxic epidermal necrolysis: a case report

Journal of Medical Case Reports, 2012
Introduction Toxic epidermal necrolysis lies within the spectrum of severe cutaneous adverse reactions induced by drugs, affecting skin and mucous membranes.
Kamal Tamer, Elnikety Sherif, Mashaly Heba, Casha James   +3 more
doaj   +1 more source

Toxic Epidermal Necrolysis

Journal of Rawalpindi Medical College, 2020
Toxic epidermal necrolysis (TEN) is the most severe form of drug-induced skin reaction and includes denudation of >30% of total body surface area. The mechanism of disease is not completely understood, but immunologic mechanisms, cytotoxic reactions, and
Syed Naveed Ali Shah, Ifaza Tariq, Muhammad Nauman Zafar   +2 more
doaj  

Carbamazepine-Induced Toxic Epidermal Necrolysis

Journal of Integrated Health Sciences, 2018
Toxic epidermal necrolysis (TEN) is an uncommon; however, life-threatening dermatological condition which occurs most frequently by the use of drugs. Some group of medications, such as antiepileptics, antibiotics as well as antivirals, can induce such ...
Kushal Gohel, Rashmi Mahajan, Megha Patel, Harsh Patel   +3 more
doaj   +1 more source

HLA‐B*15:21 carrier status is a susceptibility factor of carbamazepine‐induced nonimmediate cutaneous adverse reactions in HLA‐B*15:02‐negative patients: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
After HLA‐B*15:02 screening, the residual risk of carbamazepine‐induced nonimmediate cutaneous adverse reactions is 0.059. Among these HLA‐B*15:02‐negative cases, HLA‐B*15:11 and HLA‐B*15:21 carrier status significantly increases the risk of carbamazepine‐induced nonimmediate cADR.
Warit Ruanglertboon, Chutima Seree‐aphinan, Antida Sangiemchoey, Khwanchanok Kaewpiboon, Taweesak Maneerot, Oradawan Plong‐on, Pornsiri Sangmanee, Punthipa Nichanon, Jariya Khayman, Jiraphan Manee, Areerat Hnoonual, Kanoot Jaruthamsophon   +11 more
wiley   +1 more source